摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-5-硝基苯甲醛 | 84459-32-5

中文名称
2-溴-5-硝基苯甲醛
中文别名
——
英文名称
2-bromo-5-nitrobenzaldehyde
英文别名
——
2-溴-5-硝基苯甲醛化学式
CAS
84459-32-5
化学式
C7H4BrNO3
mdl
——
分子量
230.018
InChiKey
LJASZNNBVOTAAN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    105-107 °C
  • 沸点:
    307.2±27.0 °C(Predicted)
  • 密度:
    1.781

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.9
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2913000090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温

SDS

SDS:c1d542f01f58650de1ee8ba494a00abc
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Bromo-5-nitrobenzaldehyde
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-5-nitrobenzaldehyde
CAS number: 84459-32-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H4BrNO3
Molecular weight: 230.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-5-硝基苯甲醛盐酸羟胺三乙胺三氟乙酸酐 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 4.0h, 生成 2-溴-5-硝基苯甲腈
    参考文献:
    名称:
    一种3,5-二取代恶二唑化合物的制备方法
    摘要:
    本发明公开了一种3,5‑二取代恶二唑化合物N‑((3‑(2‑溴‑5‑硝基苯基)‑1,2,4‑恶二唑‑5‑基)甲基)乙胺的制备方法,以4‑硝基溴苯为起始原料,经过醛基化、肟化、消除、加成、关环、取代反应得到目标产物7,本发明产物作为模板小分子来合成多种多样的化合物库。
    公开号:
    CN108299333A
  • 作为产物:
    描述:
    邻溴苯甲醛硫酸硝酸 作用下, 以68%的产率得到2-溴-5-硝基苯甲醛
    参考文献:
    名称:
    1 H-茚2-甲醛衍生物的有机催化区域特异性合成:通过使用空间要求苛刻的催化剂来抑制环烯烃异构化†
    摘要:
    1 H-茚-2-甲醛衍生物的区域特异性合成是通过在氨基催化剂存在下用Hantzsch酯进行无过渡金属还原的邻甲酰基反式肉桂醛的环化反应而实现的。特别地,通过引入空间上需要的立体确定的氨基催化剂,可以有效地抑制所得产物的环烯烃异构化。
    DOI:
    10.1039/c6ob01918h
点击查看最新优质反应信息

文献信息

  • SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
    申请人:GLAXOSMITHKLINE LLC
    公开号:US20150152108A1
    公开(公告)日:2015-06-04
    The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
    本发明涉及新型取代桥式化合物,相应的相关类似物,药物组合物以及其使用方法。本发明的抑制素调节化合物可用于延长细胞寿命,并治疗和/或预防各种疾病和疾病,包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块疾病、炎症、癌症和/或潮红有关的疾病或疾病,以及那些会受益于增加线粒体活性的疾病或疾病。本发明还涉及包含抑制素调节化合物与另一治疗剂组合的组合物。
  • Relay Catalysis: Enantioselective Synthesis of Cyclic Benzo-Fused Homoallylic Alcohols by Chiral Brønsted Acid-Catalyzed Allylboration/Ring Closing Metathesis
    作者:Santos Fustero、Elsa Rodríguez、Rubén Lázaro、Lidia Herrera、Silvia Catalán、Pablo Barrio
    DOI:10.1002/adsc.201201095
    日期:2013.4.15
    Six‐ and seven‐membered benzo‐fused cyclic homoallylic alcohols can be readily synthesized by a tandem chiral Brønsted acid‐catalyzed allyl (crotyl)boration/ring closing metathesis sequence performed under orthogonal relay catalysis conditions. Excellent enantio‐ and diastereoselectivities are obtained in most of the cases. In addition, the parent crotylboration/RCM process is also described. The required
    通过在正交中继催化条件下进行串联的手性布朗斯台德酸催化的烯丙基(巴豆基)硼酸酯/环闭合复分解序列,可以轻松合成六元和七元苯并稠合的环状均丙醇。在大多数情况下,均具有出色的对映选择性和非对映选择性。另外,还描述了母体巴豆化/ RCM方法。所需的基材,邻位乙烯基苯甲醛可以很容易地一步一步从市售原料中获得。催化剂和反应物也可以从商业供应商处获得。该反应显示出广泛的官能团相容性,也适用于杂芳族底物。在芳香环的任何位置都可以取代;然而,在6位的取代导致对映选择性的大幅下降。
  • A Short Approach to N-Aryl-1,2,3,4-tetrahydroisoquinolines from N-(2-Bromobenzyl)anilines via a Reductive Amination/Palladium-Catalyzed Ethoxyvinylation/Reductive N-Alkylation Sequence
    作者:Franz Bracher、Carina Glas、Ricky Wirawan
    DOI:10.1055/s-0040-1706002
    日期:2021.6
    Starting from readily available ortho-brominated aromatic aldehydes and primary aromatic amines, condensation of these building blocks under reductive conditions gives N-aryl 2-bromobenzylamines. The C-3/C-4-unit of the tetrahydroisoquinoline is introduced using commercially available 2-ethoxyvinyl pinacolboronate under Suzuki conditions. Finally, the obtained crude ortho-ethoxyvinyl benzylamines are cyclized
    N-芳基-1,2,3,4-四氢异喹啉是通过方便且简短的方法获得的,在芳环上均具有宽范围的取代基,且官能团耐受性高。从容易获得的邻代芳族醛和伯芳族胺开始,这些结构单元在还原条件下的缩合得到N-芳基2-苄基胺。在铃木条件下,使用可商购的2-乙氧基乙烯基频哪醇硼酸酯引入四氢异喹啉的C-3 / C-4-单元。最后,使用三乙基硅烷/ TFA的组合,通过分子内的还原胺化作用,将获得的粗制邻乙氧基乙烯基苄基胺环化,得到所需的N-芳基-1,2,3,4-四氢异喹啉
  • Tandem Nucleophilic Addition−Intramolecular Aza-Michael Reaction: Facile Synthesis of Chiral Fluorinated Isoindolines
    作者:Santos Fustero、Javier Moscardó、María Sánchez-Roselló、Elsa Rodríguez、Pablo Barrio
    DOI:10.1021/ol102341n
    日期:2010.12.3
    A highly stereoselective synthesis of fluorinated 1,3-disubstituted isoindolines is described. To this end, a tandem reaction consisting of a diastereoselective addition of fluorinated nucleophiles to Ellman’s N-(tert-butanesulfinyl)imines followed by an intramolecular aza-Michael reaction has been developed. This strategy allows for the construction of isoindolines bearing several degrees of fluorination
    描述了化的1,3-二取代的异吲哚啉的高度立体选择性的合成。为此,已经开发了一种串联反应,该串联反应包括将化的亲核试剂非对映选择性地加至Ellman的N-(叔丁烷亚磺酰基)亚胺,然后进行分子内的氮杂-Michael反应。该策略允许构建带有数个化度的异二氢吲哚(单,二或三甲基以及更重的化基团)。在大多数情况下,产物都是单一异构体形式。
  • Denitrogenative Hydrotrifluoromethylation of Benzaldehyde Hydrazones: Synthesis of (2,2,2‐Trifluoroethyl)arenes
    作者:Zhensheng Zhao、Kevin C. Y. Ma、Claude Y. Legault、Graham K. Murphy
    DOI:10.1002/chem.201902818
    日期:——
    hydrazones of arylaldehydes with Togni's CF3 -benziodoxolone reagent, in the presence of potassium hydroxide and cesium fluoride, induces a denitrogenative hydrotrifluoromethylation event to produce (2,2,2-trifluoroethyl)arenes. This novel reaction was tolerant to many electronically-diverse functional groups and substitution patterns, as well as naphthyl- and heteroaryl-derived substrates. Advantages of this
    氢氧化钾氟化铯的存在下,芳基醛的azo与Togni的CF3-苯并恶唑酮试剂反应,会引发脱氮加氢三甲基化反应,从而生成(2,2,2-三氟乙基芳烃。这种新颖的反应可耐受许多电子多样性的官能团和取代方式,以及基和杂芳基衍生的底物。该方法的优点包括容易大规模获得speed前体,速度和操作简便性,并且不含过渡属。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫